ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 60 filers reported holding ONCOCYTE CORP in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $27,000 | -18.2% | 36,600 | 0.0% | 0.00% | – |
| Q2 2022 | $33,000 | -46.8% | 36,600 | -12.0% | 0.00% | – |
| Q1 2022 | $62,000 | +5.1% | 41,578 | +53.5% | 0.00% | – |
| Q4 2021 | $59,000 | -43.3% | 27,078 | -6.9% | 0.00% | – |
| Q3 2021 | $104,000 | -37.3% | 29,078 | +0.7% | 0.00% | – |
| Q2 2021 | $166,000 | -32.2% | 28,878 | -38.9% | 0.00% | – |
| Q1 2021 | $245,000 | – | 47,273 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 23,353,697 | $17,048,000 | 1.30% |
| AWM Investment Company, Inc. | 7,746,557 | $5,655,000 | 0.86% |
| PURA VIDA INVESTMENTS, LLC | 18,056,274 | $13,181,000 | 0.76% |
| Defender Capital, LLC. | 2,551,980 | $1,883,000 | 0.74% |
| Penbrook Management LLC | 563,350 | $411,000 | 0.35% |
| ACT CAPITAL MANAGEMENT, LLC | 330,000 | $241,000 | 0.33% |
| CALIBER WEALTH MANAGEMENT, LLC | 75,120 | $55,000 | 0.04% |
| Fort Sheridan Advisors LLC | 135,000 | $99,000 | 0.03% |
| Orbimed Advisors | 1,882,768 | $1,374,000 | 0.03% |
| WEALTH EFFECTS LLC | 51,000 | $37,000 | 0.02% |